BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Elixir Medical Corporation Unveils Transformational DynamX™ Stent Featuring Adaptive Segments that Uncage the Stented Artery

  Elixir Medical Corporation unveiled for the first time its novel stent technology, DynamX, a bioadaptive drug eluting stent (BA-DES) platform at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Denver.

  October 31, 2017

   · 

  3 min read
• FDA

  Sensus Healthcare Announces Clearance to Market the SRT-100 in Mexico

  Sensus Healthcare’s SRT-100 is now cleared for sale in Mexico and is approved for the treatment of non-melanoma skin cancer and keloids.

  October 31, 2017

   · 

  6 min read
• Business

  Synthetic Genomics and Ceva Enter Agreement to Develop, Commercialize Next-Generation Vaccines for Animal Health

  Synthetic Genomics announced today that the company has entered into a collaboration with Ceva Sante Animale to utilize Synthetic Genomics’ next-generation synthetic RNA replicon platform to develop vaccines for livestock.

  October 31, 2017

   · 

  2 min read
• Business

  Innophos Holdings Reports Third-Quarter 2017 Results

  Q3 earnings performance exceeded expectations; strongest adjusted diluted EPS performance in twelve quarters

  October 31, 2017

   · 

  50 min read
• Business

  Bio-Techne Corp. Declares Dividend

  The quarterly dividend will be payable November 24, 2017 to all common shareholders of record on November 10, 2017.

  October 31, 2017

   · 

  1 min read
• Biotech Beach

  Inhibrx Wins CARB-X Award of Up to $6M To Accelerate Development of its Novel Antibody, INBRX-111, to Treat Pseudomonas Infections

  InhibRx announced today a significant collaboration with CARB-X.

  October 31, 2017

   · 

  3 min read
• Heska Extends Product Line With New Element COAG Veterinary Analyzer

  Heska announced today the release of the new Element COAG Veterinary Analyzer.

  October 31, 2017

   · 

  3 min read
• Business

  Xencor to Host Third Quarter 2017 Financial Results Webcast and Conference Call on November 7, 2017

  Xencor announced that it will release third quarter 2017 financial results after the market closes on Tuesday, November 7, 2017.

  October 31, 2017

   · 

  1 min read
• Business

  Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2018

  Array BioPharma today reported results for its first quarter of fiscal 2018 and provided an update on the progress of its key clinical development programs.

  October 31, 2017

   · 

  24 min read
• Drug Development

  Impel NeuroPharma Announces First Patient Dosed in Phase I Clinical Trial of INP104 for Treatment of Acute Migraine Headache

  The Phase I trial will investigate the comparative bioavailability of INP104 versus two approved DHE formulations.

  October 31, 2017

   · 

  3 min read